J82.83 Eosinophilic asthma

Name of the Condition

• Eosinophilic Asthma (ICD Code J82.83)

Summary

• Eosinophilic asthma is a subtype of asthma characterized by high levels of eosinophils, a type of white blood cell, in the lungs and blood. This condition often presents more severe symptoms and may require specialized treatment.

Causes

• The exact cause is unknown, but it is thought to be related to genetic factors and an overactive immune response. Environmental triggers, like allergens or irritants, may also play a role.

Risk Factors

• Family history of asthma or allergies
• Obesity
• Smoking or exposure to secondhand smoke
• Exposure to allergens and pollutants

Symptoms

• Persistent cough
• Wheezing
• Breathlessness
• Stubborn asthma symptoms despite standard treatments
• Increased mucus production

Diagnosis

• Blood tests to check eosinophil levels
• Pulmonary function tests to assess lung function
• Allergy testing to determine specific triggers

Treatment Options

• Corticosteroids to reduce inflammation
• Biologic therapies targeting specific pathways in eosinophilic asthma
• Bronchodilators to relieve symptoms
• Immunotherapy for allergy management

Prognosis and Follow-Up

• With proper treatment, patients can manage symptoms effectively. Regular follow-ups are essential to adjusting treatment plans and monitoring lung function and eosinophil levels.

Complications

• Increased risk of asthma attacks and hospitalization
• Potential for permanent airway damage if left untreated

Lifestyle & Prevention

• Avoid known asthma triggers and allergens
• Maintain a healthy weight and an active lifestyle
• Adhere to prescribed asthma action plans

When to Seek Professional Help

• Sudden or severe shortness of breath
• Persistent cough or wheezing not relieved by medication
• If asthma symptoms worsen over time

Additional Resources

• American Academy of Allergy, Asthma & Immunology (AAAAI)
• Asthma and Allergy Foundation of America (AAFA)
• Global Initiative for Asthma (GINA)

Tips for Medical Coders

• Ensure complete and accurate documentation of the condition, including eosinophil levels.
• Be aware of different asthma subtypes for precise coding; eosinophilic asthma has a specific code.
• Verify all related treatments and therapies are appropriately documented for comprehensive coding.